XUFB.L vs. XGES.L

Last updated Jun 5, 2026

XUFB.L (Xtrackers MSCI USA Banks UCITS ETF 1D) and XGES.L (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both exchange-traded funds - XUFB.L is a Financials Equities fund tracking the MSCI World/Financials NR USD, while XGES.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD. Both are passively managed. Over the past 3 years, XUFB.L returned 27.41%/yr vs 1.51%/yr for XGES.L. At a 0.40 correlation, their price movements are largely independent. XUFB.L charges 0.12%/yr vs 0.35%/yr for XGES.L.

Performance

XUFB.L vs. XGES.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Xtrackers MSCI USA Banks UCITS ETF 1D (XUFB.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

XUFB.L is traded in GBp, while XGES.L is traded in GBP. To make them comparable, the XGES.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, XUFB.L achieves a -0.52% return, which is significantly higher than XGES.L's -0.81% return.

XUFB.L

• 1D: 4.38%
• 1M: 2.37%
• YTD: -0.52%
• 6M: 2.50%
• 1Y: 27.56%
• 3Y*: 27.41%
• 5Y*: 10.89%
• 10Y*: —

XGES.L

• 1D: 4.22%
• 1M: 6.75%
• YTD: -0.81%
• 6M: -4.42%
• 1Y: 26.00%
• 3Y*: 1.51%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XUFB.L vs. XGES.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
XUFB.L Xtrackers MSCI USA Banks UCITS ETF 1D	-0.52%	23.40%	40.02%	5.21%	0.38%
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	-0.81%	11.22%	-1.38%	-7.92%	-8.46%

Correlation

The correlation between XUFB.L and XGES.L is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.37
Correlation (All Time) Calculated using the full available price history since Jul 21, 2022	0.40

The correlation between XUFB.L and XGES.L shifts across timeframes, from 0.27 (1 year) to 0.40 (all time), reflecting how their relationship changes across market environments.

Return for Risk

XUFB.L vs. XGES.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XUFB.L

XUFB.L Risk / Return Rank: 37
XUFB.L Sharpe Ratio Rank: 38
XUFB.L Sortino Ratio Rank: 37
XUFB.L Omega Ratio Rank: 36
XUFB.L Calmar Ratio Rank: 39
XUFB.L Martin Ratio Rank: 34

XGES.L

XGES.L Risk / Return Rank: 37
XGES.L Sharpe Ratio Rank: 42
XGES.L Sortino Ratio Rank: 43
XGES.L Omega Ratio Rank: 38
XGES.L Calmar Ratio Rank: 35
XGES.L Martin Ratio Rank: 29

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XUFB.L vs. XGES.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI USA Banks UCITS ETF 1D (XUFB.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XUFB.L	XGES.L	Difference
Sharpe ratio: Return per unit of total volatility	1.36	1.45	-0.09
Sortino ratio: Return per unit of downside risk	1.89	2.15	-0.26
Omega ratio: Gain probability vs. loss probability	1.24	1.25	-0.01
Calmar ratio: Return relative to maximum drawdown	1.92	1.69	+0.22
Martin ratio: Return relative to average drawdown	5.08	4.09	+0.99
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XUFB.L vs. XGES.L - Sharpe Ratio Comparison

The current XUFB.L Sharpe Ratio is 1.36, which is comparable to the XGES.L Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of XUFB.L and XGES.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XUFB.L	XGES.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.36	1.45	-0.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.45	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.44	-0.12	+0.56

Drawdowns

XUFB.L vs. XGES.L - Drawdown Comparison

The maximum XUFB.L drawdown since its inception was -41.84%, which is greater than XGES.L's maximum drawdown of -35.79%. Use the drawdown chart below to compare losses from any high point for XUFB.L and XGES.L.

Drawdown Indicators

	XUFB.L	XGES.L	Difference
Max Drawdown Largest peak-to-trough decline	-41.84%	-35.79%	-6.05%
Max Drawdown (1Y) Largest decline over 1 year	-14.33%	-15.29%	+0.96%
Max Drawdown (3Y) Largest decline over 3 years	-27.91%	-25.52%	-2.39%
Max Drawdown (5Y) Largest decline over 5 years	-34.18%	—	—
Current Drawdown Current decline from peak	-3.68%	-12.59%	+8.91%
Average Drawdown Average peak-to-trough decline	-12.33%	-17.98%	+5.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.41%	6.34%	-0.93%

Volatility

XUFB.L vs. XGES.L - Volatility Comparison

Xtrackers MSCI USA Banks UCITS ETF 1D (XUFB.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) have volatilities of 6.55% and 6.45%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XUFB.L	XGES.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.55%	6.45%	+0.10%
Volatility (6M) Calculated over the trailing 6-month period	15.77%	13.62%	+2.15%
Volatility (1Y) Calculated over the trailing 1-year period	20.12%	17.84%	+2.28%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.14%	18.27%	+5.87%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.85%	18.27%	+10.58%

XUFB.L vs. XGES.L - Expense Ratio Comparison

XUFB.L has a 0.12% expense ratio, which is lower than XGES.L's 0.35% expense ratio.

Dividends

XUFB.L vs. XGES.L - Dividend Comparison

XUFB.L's dividend yield for the trailing twelve months is around 1.76%, while XGES.L has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XUFB.L Xtrackers MSCI USA Banks UCITS ETF 1D	1.76%	1.71%	1.92%	2.54%	3.43%	1.76%

Frequently Asked Questions

Can I hold both XUFB.L and XGES.L in my portfolio?

XUFB.L and XGES.L have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, XUFB.L or XGES.L?

On fees, XUFB.L is cheaper at 0.12% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, XUFB.L or XGES.L?

XUFB.L is cheaper with a 0.12% expense ratio, compared with 0.35% for XGES.L.

What is the main difference between XUFB.L and XGES.L?

XUFB.L is categorized as Financials Equities, while XGES.L is Health & Biotech Equities. XUFB.L tracks MSCI World/Financials NR USD, while XGES.L tracks MSCI World/Health Care NR USD. Their fees differ too: 0.12% for XUFB.L and 0.35% for XGES.L.